Basement membrane in pancreatic islet function

Advances in Experimental Medicine and Biology

Volumn 654, Issue , 2010, Pages 217-234

  Kragl, Martin ^b   Lammert, Eckhard ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b NONE

Author keywords

1 integrin; Basement membrane; Blood vessels; Collagen; Laminin

Indexed keywords

CELL SURFACE RECEPTOR; COLLAGEN TYPE 4; DYSTROGLYCAN; ENTACTIN; GLYCOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTEGRIN; LUTHERAN GLYCOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; PROTEOHEPARAN SULFATE; RHO KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN A; BETA1 INTEGRIN; COLLAGEN; LAMININ;

ARTICLE; BASEMENT MEMBRANE; CELL ADHESION; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; EXTRACELLULAR MATRIX; GLUCOSE TOLERANCE; HUMAN; INSULIN RELEASE; LIGAND BINDING; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; BLOOD VESSEL; CELL MEMBRANE; CHEMICAL STRUCTURE; CYTOLOGY; METABOLISM; MOUSE; REVIEW;

ANIMALS; ANTIGENS, CD29; BASEMENT MEMBRANE; BLOOD VESSELS; CELL MEMBRANE; CELL PROLIFERATION; COLLAGEN; GLYCOPROTEINS; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; LAMININ; MICE; MODELS, BIOLOGICAL; MODELS, MOLECULAR;

EID: 77953943557     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-90-481-3271-3_10     Document Type: Article

References (121)

1. Vracko R. Significance of basal lamina for regeneration of injured lung. Virchows Arch A Pathol Pathol Anat 1972;355:264-74.
2. Vracko R. Basal lamina scaffold-anatomy and significance for maintenance of orderly tissue structure. Am J Pathol 1974;77:314-46.
3. Vracko R, Benditt EP. Capillary basal lamina thickening. Its relationship to endothelial cell death and replacement. J Cell Biol 1970;47:281-5.
4. Vracko R, Benditt EP. Basal lamina: the scaffold for orderly cell replacement. Observations on regeneration of injured skeletal muscle fibers and capillaries. J Cell Biol 1972;55:406-19.
5. Paulsson M. Basement membrane proteins: structure, assembly, and cellular interactions. Crit Rev Biochem Mol Biol 1992;27:93-127.
6. Schittny JC, Yurchenco PD. Basement membranes: molecular organization and function in development and disease. Curr Opin Cell Biol 1989;1:983-8. (Pubitemid 20044900)
7. Aumailley M, Timpl R. Attachment of cells to basement membrane collagen type IV. J Cell Biol 1986;103:1569-75. (Pubitemid 17174179)
8. Yurchenco PD, Schittny JC. Molecular architecture of basement membranes. Faseb J 1990;4:1577-90.
9. Cheng YS, Champliaud MF, Burgeson RE, Marinkovich MP, Yurchenco PD. Self-assembly of laminin isoforms. J Biol Chem 1997;272:31525-32. (Pubitemid 28013294)
10. Colognato H, Yurchenco PD. Form and function: the laminin family of heterotrimers. Dev Dyn 2000;218:213-34. (Pubitemid 30349637)
11. Hudson BG, Reeders ST, Tryggvason K. Type IV collagen: structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis. J Biol Chem 1993;268:26033-36. (Pubitemid 23361657)
12. Kalluri R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 2003;3:422-33. (Pubitemid 37328846)
13. Kaido T, Yebra M, Cirulli V, Montgomery AM. Regulation of human beta-cell adhesion, motility, and insulin secretion by collagen IV and its receptor alpha1beta1. J Biol Chem 2004;279:53762-9. (Pubitemid 40051885)
14. Nikolova G, Jabs N, Konstantinova I, Domogatskaya A, Tryggvason K, Sorokin L, Fassler R, Gu G, Gerber HP, Ferrara N, Melton DA, Lammert E. The vascular basement membrane: a niche for insulin gene expression and Beta cell proliferation. Dev Cell 2006;10:397-405.
15. Timpl R,Wiedemann H, van Delden V, Furthmayr H, Kuhn K. A network model for the organization of type IV collagen molecules in basement membranes. Eur J Biochem 1981;120. 203-11. (Pubitemid 12221838)
16. Yurchenco PD, Furthmayr H. Self-assembly of basement membrane collagen. Biochemistry 1984;23:1839-50. (Pubitemid 14139823)
17. Boutaud A, Borza DB, Bondar O, Gunwar S, Netzer KO, Singh N, Ninomiya Y, Sado Y, Noelken ME, Hudson BG. Type IV collagen of the glomerular basement membrane. Evidence that the chain specificity of network assembly is encoded by the noncollagenous NC1 domains. J Biol Chem 2000;275:30716-24.
18. Yurchenco PD, Smirnov S, Mathus T. Analysis of basement membrane self-assembly and cellular interactions with native and recombinant glycoproteins. Methods Cell Biol 2002;69:111-44. (Pubitemid 44245291)
19. Poschl E, Schlotzer-Schrehardt U, Brachvogel B, Saito K, Ninomiya Y, Mayer U. Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development 2004;131:1619-28. (Pubitemid 38559288)
20. Borchiellini C, Coulon J, Le Parco Y. The function of type IV collagen during Drosophila muscle development. Mech Dev 1996;58:179-91. (Pubitemid 26302235)
21. Gupta MC, Graham PL, Kramer JM. Characterization of alpha1(IV) collagen mutations in Caenorhabditis elegans and the effects of alpha1 and alpha2(IV) mutations on type IV collagen distribution. J Cell Biol 1997;137:1185-96. (Pubitemid 27251052)
22. Kaido T, Yebra M, Cirulli V, Rhodes C, Diaferia G, Montgomery AM. Impact of defined matrix interactions on insulin production by cultured human beta-cells: effect on insulin content, secretion, and gene transcription. Diabetes 2006;55:2723-9. (Pubitemid 44923670)
23. Chung AE, Jaffe R, Freeman IL, Vergnes JP, Braginski JE, Carlin B. Properties of a basement membrane-related glycoprotein synthesized in culture by a mouse embryonal carcinomaderived cell line. Cell 1979;16:277-87. (Pubitemid 9124134)
24. Miner JH, Yurchenco PD. Laminin functions in tissue morphogenesis. Annu Rev Cell Dev Biol 2004;20:255-84. (Pubitemid 39488639)
25. Timpl R, Rohde H, Robey PG, Rennard SI, Foidart JM, Martin GR. Laminin-a glycoprotein from basement membranes. J Biol Chem 1979;254:9933-7.
26. Aumailley M, Bruckner-Tuderman L, Carter WG, Deutzmann R, Edgar D, Ekblom P, Engel J, Engvall E, Hohenester E, Jones JC, Kleinman HK, Marinkovich MP, Martin GR, Mayer U, Meneguzzi G, Miner JH, Miyazaki K, Patarroyo M, Paulsson M, Quaranta V, Sanes JR, Sasaki T, Sekiguchi K, Sorokin LM, Talts JF, Tryggvason K, Uitto J, Virtanen I, von der Mark K, Wewer UM, Yamada Y, Yurchenco PD. A simplified laminin nomenclature. Matrix Biol 2005;24:326-32. (Pubitemid 41021635)
27. Chen MS, Almeida EA, Huovila AP, Takahashi Y, Shaw LM, Mercurio AM, White JM. Evidence that distinct states of the integrin alpha6beta1 interact with laminin and an ADAM. J Cell Biol 1999;144:549-61. (Pubitemid 29234533)
28. Sasaki T, Timpl R. Domain IVa of laminin alpha5 chain is cell-adhesive and binds beta1 and alphaVbeta3 integrins through Arg-Gly-Asp. FEBS Lett 2001;509:181-85. (Pubitemid 34015939)
29. Timpl R, Brown JC. Supramolecular assembly of basement membranes. Bioessays 1996;18:123-32.
30. Yurchenco PD, Cheng YS, Colognato H. Laminin forms an independent network in basement membranes. J Cell Biol 1992;117:1119-33.
31. Ettner N, Gohring W, Sasaki T, Mann K, Timpl R. The N-terminal globular domain of the laminin alpha1 chain binds to alpha1beta1 and alpha2beta1 integrins and to the heparan sulfate-containing domains of perlecan. FEBS Lett 1998;430:217-21. (Pubitemid 28337916)
32. Mayer U, Kohfeldt E, Timpl R. Structural and genetic analysis of laminin-nidogen interaction. Ann N Y Acad Sci 1998;857:130-42. (Pubitemid 28526262)
33. Willem M, Miosge N, Halfter W, Smyth N, Jannetti I, Burghart E, Timpl R, Mayer U. Specific ablation of the nidogen-binding site in the laminin gamma1 chain interferes with kidney and lung development. Development 2002;129:2711-22. (Pubitemid 34874254)
34. Schittny JC, Yurchenco PD. Terminal short arm domains of basement membrane laminin are critical for its self-assembly. J Cell Biol 1990;110:825-32.
35. Fukumoto S, Miner JH, Ida H, Fukumoto E, Yuasa K, Miyazaki H, Hoffman MP, Yamada Y. Laminin alpha5 is required for dental epithelium growth and polarity and the development of tooth bud and shape. J Biol Chem 2006;281:5008-16. (Pubitemid 43847764)
36. Li J, Tzu J, Chen Y, Zhang YP, Nguyen NT, Gao J, Bradley M, Keene DR, Oro AE, Miner JH, MarinkovichMP. Laminin-10 is crucial for hair morphogenesis. Embo J 2003;22: 2400-10. (Pubitemid 36604979)
37. Miner JH, Li C. Defective glomerulogenesis in the absence of laminin alpha5 demonstrates a developmental role for the kidney glomerular basement membrane. Dev Biol 2000;217: 278-89. (Pubitemid 30060876)
38. Patton BL, Cunningham JM, Thyboll J, Kortesmaa J, Westerblad H, Edstrom L, Tryggvason K, Sanes JR. Properly formed but improperly localized synaptic specializations in the absence of laminin alpha4. Nat Neurosci 2001;4:597-604. (Pubitemid 32507373)
39. Thyboll J, Kortesmaa J, Cao R, Soininen R, Wang L, Iivanainen A, Sorokin L, Risling M, Cao Y, Tryggvason K. Deletion of the laminin alpha4 chain leads to impaired microvessel maturation. Mol Cell Biol 2002;22:1194-1202. (Pubitemid 34094855)
40. Wallquist W, Plantman S, Thams S, Thyboll J, Kortesmaa J, Lannergren J, Domogatskaya A, Ogren SO, Risling M, Hammarberg H, Tryggvason K, Cullheim S. Impeded interaction between Schwann cells and axons in the absence of laminin alpha4. J Neurosci 2005;25:3692-3700.
41. Carlin B, Jaffe R, Bender B, Chung AE. Entactin, a novel basal lamina-associated sulfated glycoprotein. J Biol Chem 1981;256:5209-14.
42. Fox JW, Mayer U, Nischt R, Aumailley M, Reinhardt D, Wiedemann H, Mann K, Timpl R, Krieg T, Engel J, et al.. Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. Embo J 1991;10:3137-46. (Pubitemid 21905336)
43. Kimura N, Toyoshima T, Kojima T, Shimane M. Entactin-2: a new member of basement membrane protein with high homology to entactin/nidogen. Exp Cell Res 1998;241:36-45. (Pubitemid 28366577)
44. Kohfeldt E, Sasaki T, Gohring W, Timpl R. Nidogen-2: a new basement membrane protein with diverse binding properties. J Mol Biol 1998;282:99-109. (Pubitemid 28418662)
45. Irving-Rodgers HF, Ziolkowski AF, Parish CR, Sado Y, Ninomiya Y, Simeonovic CJ, Rodgers RJ. Molecular composition of the peri-islet basement membrane in NOD mice: a barrier against destructive insulitis. Diabetologia 2008;51:1680-8.
46. Aumailley M, Battaglia C, Mayer U, Reinhardt D, Nischt R, Timpl R, Fox JW. Nidogen mediates the formation of ternary complexes of basement membrane components. Kidney Int 1993;43:7-12. (Pubitemid 23167438)
47. Aumailley M, Wiedemann H, Mann K, Timpl R. Binding of nidogen and the lamininnidogen complex to basement membrane collagen type IV. Eur J Biochem 1989;184:241-8. (Pubitemid 19229241)
48. Murshed M, Smyth N, Miosge N, Karolat J, Krieg T, Paulsson M, Nischt R. The absence of nidogen 1 does not affect murine basement membrane formation. Mol Cell Biol 2000;20:7007-12.
49. Schymeinsky J, Nedbal S, Miosge N, Poschl E, Rao C, Beier DR, Skarnes WC, Timpl R, Bader BL. Gene structure and functional analysis of the mouse nidogen-2 gene: nidogen-2 is not essential for basement membrane formation in mice. Mol Cell Biol 2002;22:6820-30.
50. Bader BL, Smyth N, Nedbal S,Miosge N, Baranowsky A, Mokkapati S, Murshed M, Nischt R. Compound genetic ablation of nidogen 1 and 2 causes basement membrane defects and perinatal lethality in mice. Mol Cell Biol 2005;25:6846-56. (Pubitemid 41023254)
51. Hacker U, Nybakken K, Perrimon N. Heparan sulphate proteoglycans: the sweet side of development. Nat Rev Mol Cell Biol 2005;6:530-41. (Pubitemid 40943044)
52. Lin X. Functions of heparan sulfate proteoglycans in cell signaling during development. Development 2004;131:6009-21. (Pubitemid 40123916)
53. Strigini M. Mechanisms of morphogen movement. J Neurobiol 2005;64:324-33. (Pubitemid 41114043)
54. Iozzo RV. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 1998;67:609-52. (Pubitemid 28411140)
55. Whitelock JM, Graham LD, Melrose J, Murdoch AD, Iozzo RV, Underwood PA. Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells. Matrix Biol 1999;18:163-78. (Pubitemid 29229702)
56. Arikawa-Hirasawa E, Watanabe H, Takami H, Hassell JR, Yamada Y. Perlecan is essential for cartilage and cephalic development. Nat Genet 1999;23:354-8. (Pubitemid 29526437)
57. Costell M, Gustafsson E, Aszodi A, Morgelin M, Bloch W, Hunziker E, Addicks K, Timpl R, Fassler R. Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol 1999;147:1109-22.
58. Brissova M, Shostak A, Shiota M, Wiebe PO, Poffenberger G, Kantz J, Chen Z, Carr C, Jerome WG, Chen J, Baldwin HS, Nicholson W, Bader DM, Jetton T, Gannon M, Powers AC. Pancreatic islet production of vascular endothelial growth factor-a is essential for islet vascularization, revascularization, and function. Diabetes 2006;55:2974-85. (Pubitemid 44923633)
59. Lammert E, Gu G, McLaughlin M, Brown D, Brekken R, Murtaugh LC, Gerber HP, Ferrara N, Melton DA. Role of VEGF-A in vascularization of pancreatic islets. Curr Biol 2003;13:1070-4. (Pubitemid 36726045)
60. Hart AW, Baeza N, Apelqvist A, Edlund H. Attenuation of FGF signalling in mouse betacells leads to diabetes. Nature 2000;408:864-8. (Pubitemid 32016097)
61. Kilkenny DM, Rocheleau JV. Fibroblast growth factor receptor-1 signaling in pancreatic islet beta-cells is modulated by the extracellular matrix. Mol Endocrinol 2008;22:196-205.
62. Wente W, Efanov AM, Brenner M, Kharitonenkov A, Koster A, Sandusky GE, Sewing S, Treinies I, Zitzer H, Gromada J. Fibroblast growth factor-21 improves pancreatic betacell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. Diabetes 2006;55:2470-8. (Pubitemid 44871147)
63. Dai C, Huh CG, Thorgeirsson SS, Liu Y. Beta-cell-specific ablation of the hepatocyte growth factor receptor results in reduced islet size, impaired insulin secretion, and glucose intolerance. Am J Pathol 2005;167:429-36. (Pubitemid 43026099)
64. Lopez-Talavera JC, Garcia-Ocana A, Sipula I, Takane KK, Cozar-Castellano I, Stewart AF. Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation. Endocrinology 2004;145:467-74. (Pubitemid 38183786)
65. Aumailley M, Specks U, Timpl R. Cell adhesion to type-VI collagen. Biochem Soc Trans 1991;19:843-7.
66. Aumailley M, Timpl R, Risau W. Differences in laminin fragment interactions of normal and transformed endothelial cells. Exp Cell Res 1991;196:177-83. (Pubitemid 121006389)
67. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25.
68. Sheppard D. In vivo functions of integrins: lessons from null mutations in mice. Matrix Biol 2000;19:203-9. (Pubitemid 30601753)
69. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002;110:673-87. (Pubitemid 35283958)
70. ffrench-Constant C, Colognato H. Integrins: versatile integrators of extracellular signals. Trends Cell Biol 2004;14:678-86. (Pubitemid 39572553)
71. Legate KR, Montanez E, Kudlacek O, Fassler R. ILK, PINCH and parvin: the tIPP of integrin signalling. Nat Rev Mol Cell Biol 2006;7:20-31. (Pubitemid 43361569)
72. Fassler R, MeyerM. Consequences of lack of beta 1 integrin gene expression in mice. Genes Dev 1995;9:1896-1908.
73. Li S, Bordoy R, Stanchi F, Moser M, Braun A, Kudlacek O, Wewer UM, Yurchenco PD, Fassler R. PINCH1 regulates cell-matrix and cell-cell adhesions, cell polarity and cell survival during the peri-implantation stage. J Cell Sci 2005;118:2913-21. (Pubitemid 41136368)
74. Liang X, Zhou Q, Li X, Sun Y, Lu M, Dalton N, Ross J, Jr., Chen J. PINCH1 plays an essential role in early murine embryonic development but is dispensable in ventricular cardiomyocytes. Mol Cell Biol 2005;25:3056-62. (Pubitemid 40464309)
75. Sakai T, Li S, Docheva D, Grashoff C, Sakai K, Kostka G, Braun A, Pfeifer A, Yurchenco PD, Fassler R. Integrin-linked kinase (ILK) is required for polarizing the epiblast, cell adhesion, and controlling actin accumulation. Genes Dev 2003;17:926-40. (Pubitemid 36397379)
76. Stephens LE, Sutherland AE, Klimanskaya IV, Andrieux A, Meneses J, Pedersen RA, Damsky CH. Deletion of beta 1 integrins in mice results in inner cell mass failure and peri-implantation lethality. Genes Dev 1995;9:1883-95.
77. Durbeej M, Henry MD, Ferletta M, Campbell KP, Ekblom P. Distribution of dystroglycan in normal adult mouse tissues. J Histochem Cytochem 1998;46:449-57. (Pubitemid 28158464)
78. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 1992;355:696-702.
79. Ibraghimov-Beskrovnaya O, Milatovich A, Ozcelik T, Yang B, Koepnick K, Francke U, Campbell KP. Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization. Hum Mol Genet 1993;2:1651-7. (Pubitemid 23358684)
80. Ervasti JM, Campbell KP. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 1993;122:809-23. (Pubitemid 23241091)
81. Rudenko G, Hohenester E, Muller YA. LG/LNS domains: multiple functions - one business end? Trends Biochem Sci 2001;26:363-8. (Pubitemid 32530654)
82. Gee SH, Blacher RW, Douville PJ, Provost PR, Yurchenco PD, Carbonetto S. Lamininbinding protein 120 from brain is closely related to the dystrophin-associated glycoprotein, dystroglycan, and binds with high affinity to the major heparin binding domain of laminin. J Biol Chem 1993;268:14972-80. (Pubitemid 23206646)
83. Matsumura K, Yamada H, Shimizu T, Campbell KP. Differential expression of dystrophin, utrophin and dystrophin-associated proteins in peripheral nerve. FEBS Lett 1993;334: 281-5. (Pubitemid 23341732)
84. Yamada H, Shimizu T, Tanaka T, Campbell KP, Matsumura K. Dystroglycan is a binding protein of laminin and merosin in peripheral nerve. FEBS Lett 1994;352:49-53. (Pubitemid 24291757)
85. Jung D, Yang B, Meyer J, Chamberlain JS, Campbell KP. Identification and characterization of the dystrophin anchoring site on beta-dystroglycan. J Biol Chem 1995;270:27305-10.
86. Rentschler S, Linn H, Deininger K, Bedford MT, Espanel X, Sudol M. The WW domain of dystrophin requires EF-hands region to interact with beta-dystroglycan. Biol Chem 1999;380:431-42. (Pubitemid 29204312)
87. James M, Nuttall A, Ilsley JL, Ottersbach K, Tinsley JM, Sudol M, Winder SJ. Adhesiondependent tyrosine phosphorylation of (beta)-dystroglycan regulates its interaction with utrophin. J Cell Sci 113 (Pt 2000;10):1717-26. (Pubitemid 30333121)
88. Cavaldesi M, Macchia G, Barca S, Defilippi P, Tarone G, Petrucci TC. Association of the dystroglycan complex isolated from bovine brain synaptosomes with proteins involved in signal transduction. J Neurochem 1999;72:1648-55. (Pubitemid 29140840)
89. Sotgia F, Lee H, Bedford MT, Petrucci T, Sudol M, Lisanti MP. Tyrosine phosphorylation of beta-dystroglycan at its WW domain binding motif, PPxY, recruits SH2 domain containing proteins. Biochemistry 2001;40:14585-92. (Pubitemid 33111742)
90. Sotgia F, Lee JK, Das K, Bedford M, Petrucci TC, Macioce P, Sargiacomo M, Bricarelli FD, Minetti C, Sudol M, Lisanti MP. Caveolin-3 directly interacts with the C-terminal tail of beta-dystroglycan. Identification of a central WW-like domain within caveolin family members. J Biol Chem 2000;275:38048-58. (Pubitemid 32004928)
91. Spence HJ, Chen YJ, Batchelor CL, Higginson JR, Suila H, Carpen O, Winder SJ. Ezrindependent regulation of the actin cytoskeleton by beta-dystroglycan. Hum Mol Genet 2004;13:1657-68. (Pubitemid 39136721)
92. Spence HJ, Dhillon AS, James M, Winder SJ. Dystroglycan, a scaffold for the ERK-MAP kinase cascade. EMBO Rep 2004;5:484-9. (Pubitemid 38745039)
93. Jiang FX, Georges-Labouesse E, Harrison LC. Regulation of laminin 1-induced pancreatic beta-cell differentiation by alpha6 integrin and alpha-dystroglycan. Mol Med 2001;7: 107-14. (Pubitemid 33702026)
94. Durbeej M, Campbell KP. Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr Opin Genet Dev 2002;12:349-61. (Pubitemid 34669835)
95. Haliloglu G, Topaloglu H. Glycosylation defects in muscular dystrophies. Curr Opin Neurol 2004;17:521-7. (Pubitemid 39410868)
96. Michele DE, Campbell KP. Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. J Biol Chem 2003;278:15457-60. (Pubitemid 36799650)
97. Moore SA, Saito F, Chen J, Michele DE, Henry MD, Messing A, Cohn RD, Ross-Barta SE, Westra S, Williamson RA, Hoshi T, Campbell KP. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature 2002;418:422-5. (Pubitemid 34826842)
98. Eyler CE, Telen MJ. The Lutheran glycoprotein: a multifunctional adhesion receptor. Transfusion 2006;46:668-77.
99. Kikkawa Y, Miner JH. Review: Lutheran/B-CAM: a laminin receptor on red blood cells and in various tissues. Connect Tissue Res 2005;46:193-9.
100. Kikkawa Y, Moulson CL, Virtanen I, Miner JH. Identification of the binding site for the Lutheran blood group glycoprotein on laminin alpha 5 through expression of chimeric laminin chains in vivo. J Biol Chem 2002;277:44864-9. (Pubitemid 36159081)
101. Otonkoski T, Banerjee M, Korsgren O, Thornell LE, Virtanen I. Unique basement membrane structure of human pancreatic islets: implications for beta-cell growth and differentiation. Diabetes Obes Metab 10 Suppl 2008;4:119-27.
102. Virtanen I, Banerjee M, Palgi J, Korsgren O, Lukinius A, Thornell LE, Kikkawa Y, Sekiguchi K, Hukkanen M, Konttinen YT, Otonkoski T. Blood vessels of human islets of Langerhans are surrounded by a double basement membrane. Diabetologia 2008;51:1181-91.
103. Parsons SF, Lee G, Spring FA, Willig TN, Peters LL, Gimm JA, Tanner MJ, Mohandas N, Anstee DJ, Chasis JA. Lutheran blood group glycoprotein and its newly characterized mouse homologue specifically bind alpha5 chain-containing human laminin with high affinity. Blood 2001;97:312-20. (Pubitemid 32061275)
104. Parsons SF, Mallinson G, Holmes CH, Houlihan JM, Simpson KL, Mawby WJ, Spurr NK, Warne D, Barclay AN, Anstee DJ. The Lutheran blood group glycoprotein, another member of the immunoglobulin superfamily, is widely expressed in human tissues and is developmentally regulated in human liver. Proc Natl Acad Sci U S A 1995;92:5496-5500.
105. Konstantinova I, Lammert E. Microvascular development: learning from pancreatic islets. Bioessays 2004;26:1069-75. (Pubitemid 39424810)
106. Jabs N, Franklin I, Brenner MB, Gromada J, Ferrara N, Wollheim CB, Lammert E. Reduced insulin secretion and content in VEGF-a deficient mouse pancreatic islets. Exp Clin Endocrinol Diabetes 2008;116 Suppl 1:S46-49.
107. Bosco D,Meda P, Halban PA, Rouiller DG. Importance of cell-matrix interactions in rat islet beta-cell secretion in vitro: role of alpha6beta1 integrin. Diabetes 2000;49:233-43. (Pubitemid 30071002)
108. Bosco DA, Kern D. Catalysis and binding of cyclophilin A with different HIV-1 capsid constructs. Biochemistry 2004;43:6110-9. (Pubitemid 38669479)
109. Hammar E, Tomas A, Bosco D, Halban PA. Role of the Rho-Rock (Rho-associated kinase) signaling pathway in the regulation of pancreatic beta cell function. Endocrinology 2008.
110. Hammar EB, Irminger JC, Rickenbach K, Parnaud G, Ribaux P, Bosco D, Rouiller DG, Halban PA. Activation of NF-kappaB by extracellular matrix is involved in spreading and glucose-stimulated insulin secretion of pancreatic beta cells. J Biol Chem 2005;280: 30630-7. (Pubitemid 41216249)
111. Parnaud G, Hammar E, Rouiller DG, Armanet M, Halban PA, Bosco D. Blockade of beta1 integrin-laminin-5 interaction affects spreading and insulin secretion of rat beta-cells attached on extracellular matrix. Diabetes 2006;55:1413-20. (Pubitemid 44195381)
112. Miyazaki J, Araki K, Yamato E, Ikegami H, Asano T, Shibasaki Y, Oka Y, Yamamura K. Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 1990;127:126-32. (Pubitemid 20228111)
113. Meier JJ, Lin JC, Butler AE, Galasso R, Martinez DS, Butler PC. Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes.Diabetologia 2006;49:1838-44. (Pubitemid 44025038)
114. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, Taylor DA. Perfusiondecellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008;14:213-21. (Pubitemid 351214548)
115. Danen EH, Yamada KM. Fibronectin, integrins, and growth control. J Cell Physiol 2001;189:1-13.
116. Miranti CK, Brugge JS. Sensing the environment: a historical perspective on integrin signal transduction. Nat Cell Biol 2002;4:E83-90. (Pubitemid 34308848)
117. Schwartz MA, Ginsberg MH. Networks and crosstalk: integrin signalling spreads. Nat Cell Biol 2002;4:E65-8. (Pubitemid 34308840)
118. Wu C, Dedhar S. Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol 2001;155:505-10. (Pubitemid 34289309)
119. Haenggi T, Fritschy JM. Role of dystrophin and utrophin for assembly and function of the dystrophin glycoprotein complex in non-muscle tissue. Cell Mol Life Sci 2006;63:1614-31. (Pubitemid 44252175)
120. Sgambato A, Brancaccio A. The dystroglycan complex: from biology to cancer. J Cell Physiol 2005;205:163-9. (Pubitemid 41428897)
121. Winder SJ. The complexities of dystroglycan. Trends Biochem Sci 2001;26:118-24. (Pubitemid 32144747)